USPTO 2015–2025 USPTO PatentsView US Corporation

VALENT BIOSCIENCES LLC

USPTO PatentsView assignee record — 72 granted patents across 18 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A01N (PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS).

72
Total patents granted
18
CPC technology areas
11.7
Avg claims per patent
-53%
5-year filing velocity

Portfolio overview

VALENT BIOSCIENCES LLC has been granted 72 US utility patents between 2015 and 2025, placing VALENT BIOSCIENCES LLC at rank #4,851 across all assignees tracked by PlainPatent. This portfolio spans 18 distinct Cooperative Patent Classification (CPC) subclasses, averaging 11.7 claims per patent with primary concentration in A01N (PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS). As a US Corporation, VALENT BIOSCIENCES LLC is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 40.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 23 grants, compared with 49 in the 2015–2019 window — a -53% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. VALENT BIOSCIENCES LLC's 11.7 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 18 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark VALENT BIOSCIENCES LLC against peers pursuing similar technology classes.

How does VALENT compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows VALENT holds 72 patents — placing it at rank #4,851 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

051015 20152016201720182019202020212022202320242025 4
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
VALENT BIOSCIENCES LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 5 6.9%
2016 6 8.3%
2017 14 19.4%
2018 11 15.3%
2019 13 18.1%
2020 4 5.6%
2021 4 5.6%
2022 7 9.7%
2023 1 1.4%
2024 3 4.2%
2025 4 5.6%

Which technologies does VALENT BIOSCIENCES LLC patent most?

Top 15 of 18 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Simple
Velocity Declining

Where it ranks

Overall rank by patents

#4,851

Across all tracked assignees

Innovation Score

40.4 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does VALENT BIOSCIENCES LLC hold?
VALENT BIOSCIENCES LLC holds 72 US granted patents filed between 2015 and 2025, spanning 18 technology areas.
What is VALENT BIOSCIENCES LLC's Innovation Score?
VALENT BIOSCIENCES LLC has an Innovation Score of 40.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does VALENT BIOSCIENCES LLC focus on?
VALENT BIOSCIENCES LLC's top technology area is A01N (PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS) with 67 patents. The company has filed patents in 18 CPC subclasses total.
Is VALENT BIOSCIENCES LLC's patent filing rate increasing or decreasing?
VALENT BIOSCIENCES LLC's recent filing velocity is -53% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for VALENT BIOSCIENCES LLC's patents?
VALENT BIOSCIENCES LLC's patents average 11.7 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the VALENT BIOSCIENCES LLC patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope